Back to Trials
NCT07075731Recruiting

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

University of Minnesota

Start Date

6/30/2025

Completion Date

6/30/2027

Summary

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * 18 years and older * Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent * Able to understand, speak, read, and write in English * Patients who have undergone hysterectomy, or plan to have a hysterectomy * Patients who are transgender and gender diverse" Exclusion Criteria: * Opted out of research * \<18 years old * Lacks capacity to consent/has diminished capacity to consent * Cannot provide informed consent * Those on the study's community advisory board

Interventions

OTHER

No intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cancer ScreeningTransgenderGender Diverse Populations

Locations

University of Minnesota

Minneota, Minnesota 55455

United States